Estramustine phosphate enhances the effects of hyperthermia and induces the small heat shock protein HSP27 in the human prostate carcinoma cell line PC-3

Urological Research

Volumn 30, Issue 2, 2002, Pages 130-135

  Roigas, J ^a   Wallen, E S ^b   Loening, S A ^a   Moseley, P L ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

Estramustine phosphate; Heat shock proteins; Hyperthermia; Prostate cancer

Indexed keywords

ESTRAMUSTINE PHOSPHATE; HEAT SHOCK PROTEIN 27;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE PHASE; CELL SUBPOPULATION; CLINICAL OBSERVATION; CYTOTOXICITY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; HYPERTHERMIA; IMMUNOBLOTTING; INCUBATION TIME; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS; SENSITIZATION; TEMPERATURE MEASUREMENT; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CARCINOMA; CELL CYCLE; ESTRAMUSTINE; HEAT-SHOCK PROTEINS; HSP72 HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; MALE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 0036934583     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-002-0234-9     Document Type: Article

References (34)

1. Algan O, Fosmire H, Hynynen K, Dalkin B, Cui H, Drach G, Stea B, Cassady JR (2000) External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma. Cancer 89: 399
2. Anscher MS, Samulski TV, Dodge R, Prosnitz LR, Dewhirst MW (1997) Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 37: 1059
3. Ben-Josef E, Porter AT, Han S, Mertens W, Chuba P, Fontana J, Hussain M (2000) Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: Feasibility and preliminary results. Int J Radiat Oncol Biol Phys 49: 699
4. Ciocca DR, Stati AO, Amprino de Castro MM (1990) Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue. Breast Cancer Res Treat 16: 243
5. Ciocca DR, Oesterreich S, Chamness GC, McGuire WL, Fuqua SAW (1993) Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst 85: 1558
6. Dahllöf B, Billström A, Cabral F, Hartley-Asp B (1993) Estramustine depolymerizes microtubules by binding to tubulin. Cancer Res 53: 4573
7. Deger S, Boehmer D, Turk I, Roigas J, Budach V, Loening SA (2001) Thermoradiotherapy using self-regulating interstitial thermo-seeds in combination ith conformal radiotherapy for prostate cancer. J Urol 165 [Suppl 5]: 389
8. Dermietzel R, Streffer C (1992) The cytoskeleton and proliferation of melanoma cells under hyperthermal conditions. A correlative double immuno-labelling study. Strahlenther Onkol 168: 593
9. Eklöv S, Essand M, Carlsson J, Nilsson S (1992) Radiation sensitization by estramustine studies on cultured human prostatic cancer cells. Prostate 21: 287
10. Eklöv S, Westlin JE, Rikner G, Nilsson S (1994) Estramustine potentiates the radiation effect in human prostate tumor transplant in nude mice. Prostate 24: 39
11. Fakih M, Yagoda A, Reploge T, Lehr JE, Pienta KJ (1995) Inhibition of prostate cancer growth by estramustine and colchicine. Prostate 26: 310
12. Hartley-Asp B (1984) Estramustine-induced mitotic arrest in two human prostatic carcinoma cells lines DU 145 and PC-3. Prostate 5: 93
13. Hudes G, Einhorn L, Ross E, Balsham A, Loehrer P, Ramsey H, Sprandio J, Entmacher M, Dugan W, Ansari R, Monaco F, Hanna M, Roth B (1999) Vinblastine versus vinblastine plus oral estramustine phosphate for patients with hormone-refractory prostate cancer: a Hoosier Oncology Group and Fox Chase Network phase III trial. J Clin Oncol 17: 3160
14. Huot J, Roy G, Lambert H, Chretien P, Landry J (1991) Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res 51: 5245
15. Iversen P, Rasmussen F, Asmussen C, Christensen IJ, Eickhoff J, Klarskov P, Larsen E, Mogensen S, Mommsen S, Rosenkilde P (1997) Estramustine phosphate versus placebo as second line treatment after orchiectomy in patients with metastatic prostate cancer: DAPROCA study 9002. Danish Prostatic Cancer Group. J Urol 157: 929
16. Kaighn ME, Shankar Narayan K, Ohnuki Y, Lechner JF, Jones LW (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16
17. Khil MS, Kim JH, Bricker LJ, Cerny JC (1997) Tumor control of locally advanced prostate cancer following combined estramustine, vinblastine, and radiation therapy. Cancer J Sci Am 3: 289
18. Kreis W, Budman DR, Fetten J, Gonzales AL, Barile B, Vinciguerra V (1999) Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma. Ann Oncol 10: 33
19. La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW, Linehan WM, Myers CE (1991) Effect of Suramin on human prostate cancer cells in vitro. J Urol 145: 393
20. Lau KM, LaSpina M, Long J, Ho SM (2000) Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60: 3175
21. Lavoie JN, Gingras-Breton G, Tanguay RM, Landry J (1993) Induction of Chinese hamster HSP27 gene expression in mouse cells confers resistance to heat shock. J Biol Chem 268: 3420
22. Lloyd SN, Chalmers D, Leake RE, Kirk D (1992) Local hyperthermia for prostatic disease: in vitro studies on human prostatic cancer cell lines. Br J Urol 70: 529
23. Newling DW, Fossa SD, Tunn UW, Kurth KH, de Pauw M, Sylvester R (1993) Mitomycin C versus estramustine in the treatment of hormone resistant metastatic prostate cancer: the final analysis of the European Organization for Research and Treatment of Cancer, genitourinary group prospective randomized phase III study. J Urol 150: 1840
24. Oesterreich S, Schunck H, Benndorf R, Bielka H (1991) Cisplatin induces the small heat shock protein hsp25 and thermotolerance in Ehrlich ascites tumor cells. Biochem Biophys Res Comm 180: 243
25. Pienta KJ, Lehr JE (1993) Inhibition of prostate cancer growth by estramustine and etoposide: evidence for interaction at the nuclear matrix. J Urol 149: 1622
26. Prionas SD, Kapp DS, Goffinet DR, Ben-Yosef R, Fessenden P, Bagshaw MA (1994) Thermometry of interstitial hyperthermia given as an adjuvant to brachytherapy for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 28: 151
27. Roigas J, Wallen ES, Loening SA, Moseley PL (1997) Effects of combined treatment of chemotherapeutics and hyperthermia on survival and the regulation of heat shock proteins in Dunning R3327 cells. Prostate 34: 195
28. Ryu S, Gabel M, Khiul MS, Lee YJ, Kim S, Kim JH (1994) Estramustine: a novel radiation enhancer in human carcinoma cells. Int J Radiat Oncol Biol Phys 30: 99
29. Seymour L, Bezwoda WR, Meyer K (1990) Detection of P24 protein in human breast cancer: influence of receptor status and oestrogen exposure. Br J Cancer 61: 886
30. Speicher LA, Barone L, Tew KD (1992) Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines. Cancer Res 52: 4433
31. Streffer C (1995) Molecular and cellular mechanisms of hyperthermia. In: Seegenschmidt MH, Fessenden P, Vernon CC (eds) Thermoradiotherapy and thermochemotherapy. Biology, physiology, physics, Vol 1. Springer, Berlin Heidelberg New York, p 47
32. Westra A, Dewey WC (1971) Variation in sensitivity to heat shock during the cell-cycle of Chinese hamster cells in vitro. Int J Radiat Biol 19: 467
33. Widmark A, Damber J-E, Bergh A, Henrikson R (1994) Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma. Prostate 24: 79
34. Yoshida D, Piepmeier J, Weinstein M (1994) Estramustine sensitizes human glioblastoma cells to irradiation. Cancer Res 54: 1415